Oarsman Capital, Inc. Teva Pharmaceutical Industries LTD Transaction History
Oarsman Capital, Inc.
- $562 Million
- Q4 2024
A detailed history of Oarsman Capital, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Oarsman Capital, Inc. holds 1,317 shares of TEVA stock, worth $21,901. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,317Holding current value
$21,901% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding TEVA
# of Institutions
671Shares Held
571MCall Options Held
21.1MPut Options Held
9.94M-
Black Rock Inc. New York, NY43MShares$715 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$648 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$603 Million35.87% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$472 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$452 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.5B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...